Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn moreDeveloping IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MOREReimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewGenerate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWElevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWOrchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWWhen your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSBy making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MOREBuilding on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MOREThe IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MOREThe IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MOREIQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MOREEmpowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MORE"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.
VIEW ROLESA IQVIA, um fornecedor global líder de serviços de investigação clínica, insights comerciais e inteligência em saúde, colaborou na realização de mais de 70 estudos de Primary Market Intelligence para a Indústria Farmacêutica e de MedTech em 2024, tendo como objetivo entender melhor o mercado e as necessidades dos profissionais de saúde e dos utentes. Segundo Ana Lopes, que lidera a área de PI na IQVIA em Portugal, “os resultados destes estudos fornecem insights valiosos sobre o reconhecimento das marcas, posicionamento competitivo, a jornada do utente/ consumidor e os segmentos de mercado mais relevantes para a empresa.” Em 2024, a indústria farmacêutica, em especial a área de especialidade, e de MedTech solicitaram a realização de 79% dos estudos efetuados, enquanto que a área de Consumer Health correspondeu a 21% dos estudos realizados pela IQVIA Portugal.
As áreas de especialidade lideram a solicitação de estudos de Primary Market Intelligence, sendo que as áreas de oncologia (27%), autoimunes (16%) e doenças raras (11%) lideram os estudos realizados em 2024.
Gráfico 1 – Share (%) de estudos de Primary Market Intelligence realizados pela IQVIA Portugal para o mercado Farma e MedTech em 2024.
Já no mercado de Consumer Health, os estudos mais solicitados recaem nas áreas de dermocosmética (27%), medicina estética (20%) e nutrição em oncologia (20%).
Gráfico 1 – Share (%) de estudos de Primary Market Intelligence realizados pela IQVIA Portugal para o mercado de Consumer Health em 2024.
Os estudos envolveram aproximadamente 3800 profissionais de saúde, o que demonstra o amplo alcance e a relevância das pesquisas realizadas.
A IQVIA, pelo seu posicionamento único, permite combinar dados hospitalares, de ambulatório e ainda dos canais de farmácia e parafarmácia, aos dados recolhidos aquando da realização de estudos de Primary Market Intelligence, gerando um valor único para o setor da saúde em Portugal.